pyrazines has been researched along with Orphan Diseases in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ais, A; Beaudet, A; Gil, A; Jiménez, A | 1 |
| Creamer, A; Gaastra, B; Odogwu, S; Whitelaw, B | 1 |
| Bay, JO; Ravinet, A; Tournilhac, O | 1 |
| Billingham, L; Dutton, P; Hassan, AB; Love, SB | 1 |
| Besa, E; Bray, P; Caro, J; Dulau Florea, A; Mahipal, A; Sbenghe, MM | 1 |
1 review(s) available for pyrazines and Orphan Diseases
| Article | Year |
|---|---|
[Plasma cell leukemia].
Topics: Aged; Antineoplastic Agents; Biomedical Research; Boronic Acids; Bortezomib; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Prognosis; Pyrazines; Rare Diseases; Thalidomide | 2014 |
4 other study(ies) available for pyrazines and Orphan Diseases
| Article | Year |
|---|---|
Determining the value contribution of selexipag for the treatment of pulmonary arterial hypertension (PAH) in Spain using reflective multi-criteria decision analysis (MCDA).
Topics: Acetamides; Decision Making; Decision Support Techniques; Humans; Hypertension, Pulmonary; Pyrazines; Quality of Life; Rare Diseases; Spain | 2018 |
POEMS syndrome: a challenging diagnosis of a rare disease.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; POEMS Syndrome; Pyrazines; Rare Diseases | 2014 |
Analysis of phase II methodologies for single-arm clinical trials with multiple endpoints in rare cancers: An example in Ewing's sarcoma.
Topics: Antineoplastic Agents; Bayes Theorem; Clinical Trials, Phase II as Topic; Data Interpretation, Statistical; Humans; Imidazoles; Models, Statistical; Patient Selection; Probability; Pyrazines; Rare Diseases; Sample Size; Sarcoma, Ewing; Treatment Outcome | 2018 |
HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.
Topics: Adult; Boronic Acids; Bortezomib; Castleman Disease; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV; Humans; Male; Pyrazines; Rare Diseases | 2012 |